Julia Ritterhoff, PhD
@juliaritterhoff.bsky.social
Are you on the hunt for a novel AAV vector for cardiac gene therapy? We identified a promising candidate in human heart biopsies with great potential for cardiac-directed therapies.
doi.org/10.1161/CIRC...
doi.org/10.1161/CIRC...
American Heart Association Journals
doi.org
August 13, 2025 at 7:59 PM
Are you on the hunt for a novel AAV vector for cardiac gene therapy? We identified a promising candidate in human heart biopsies with great potential for cardiac-directed therapies.
doi.org/10.1161/CIRC...
doi.org/10.1161/CIRC...
First post here on a new publication from our lab 😄😄😄
I'm excited to share our latest work on cardiac gene therapy, where we show that AAV5 is effective in delivering S100A1 to the post-ischemic heart, achieving lasting improvement in cardiac [email protected]
www.ahajournals.org/doi/10.1161/...
I'm excited to share our latest work on cardiac gene therapy, where we show that AAV5 is effective in delivering S100A1 to the post-ischemic heart, achieving lasting improvement in cardiac [email protected]
www.ahajournals.org/doi/10.1161/...
Cardiac-Targeted AAV5-S100A1 Gene Therapy Protects Against Adverse Remodeling and Contractile Dysfunction in Postischemic Hearts | Circulation: Heart Failure
BACKGROUND: Guided by long-term safety data for AAV5 (adeno-associated virus 5) in humans, our
translational study investigated whether AAV5 effectively delivers genes to healthy
and achieves therapeu...
www.ahajournals.org
June 26, 2025 at 10:19 AM
First post here on a new publication from our lab 😄😄😄
I'm excited to share our latest work on cardiac gene therapy, where we show that AAV5 is effective in delivering S100A1 to the post-ischemic heart, achieving lasting improvement in cardiac [email protected]
www.ahajournals.org/doi/10.1161/...
I'm excited to share our latest work on cardiac gene therapy, where we show that AAV5 is effective in delivering S100A1 to the post-ischemic heart, achieving lasting improvement in cardiac [email protected]
www.ahajournals.org/doi/10.1161/...
Reposted by Julia Ritterhoff, PhD
Breaking News: A baby with a rare disorder made medical history by receiving the first custom gene-editing treatment. The technique used has the potential to help people with thousands of other uncommon genetic diseases. nyti.ms/4j49xBy
May 15, 2025 at 5:09 PM
Breaking News: A baby with a rare disorder made medical history by receiving the first custom gene-editing treatment. The technique used has the potential to help people with thousands of other uncommon genetic diseases. nyti.ms/4j49xBy